Clinical care of the exposed infants of HIV-infected mothers

Clinics in Perinatology

Volumn 37, Issue 4, 2010, Pages 863-872

  Robinson, Lisa Gaye E ^a   Fernandez, Aracelis D ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

HIV exposed infant; Pediatric AIDS; Pediatric HIV; Perinatal transmission of HIV

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; LAMIVUDINE; NEVIRAPINE; PLACEBO; ZIDOVUDINE;

ANAMNESIS; ANEMIA; ANTICIPATORY GUIDANCE; BREAST FEEDING; CHEMOPROPHYLAXIS; CHILD CARE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXPOSURE; DRUG PENETRATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT FEEDING; INFECTION PREVENTION; INFECTION RISK; MOTHER; NEUTROPENIA; PHYSICAL EXAMINATION; PNEUMOCYSTIS PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; REVIEW; RISK FACTOR; SIDE EFFECT; SINGLE DRUG DOSE; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-RETROVIRAL AGENTS; BREAST FEEDING; CAREGIVERS; DELIVERY OF HEALTH CARE; FEMALE; GUIDELINES AS TOPIC; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MEDICAL RECORDS; MOTHERS; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; WORLD HEALTH;

EID: 78349232723     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clp.2010.08.008     Document Type: Review

References (35)

1. Joint United Nations Programme on HIV/AIDS and World Health Organization. AIDS epidemic update 2009 Available at:, Accessed June 13, 2010. http://www.unaids.org/pub/report/2009/JC1700_Epi_Update_2009_en.pdf.
2. Kourtis A.P., Bulterys M., Nesheim S., et al. Understanding the timing of HIV transmission from mother to child. JAMA 2001, 285(6):709-712.
3. Working Group on Mother-to-child transmission of HIV Rate of mother-to-child transmission of HIV-1 in Africa, America and Europe. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 8:506-510.
4. De Cock K.M., Fowler M.G., Mercier E., et al. Prevention of mother-to-child HIV transmission in resource poor countries. JAMA 2000, 283:1175-1182.
5. Connor E.M., Sperling R.S., Gelber R., et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trial Group Protocol 076 Study Group. N Engl J Med 1994, 331:1173-1180.
6. Vertical transmission of HIV-1: maternal immune status and obstetric factors. AIDS 1996, 10:1675-1681. The European Collaborative Study.
7. + levels. J Acquir Immune Defic Syndr 1994, 7:718-726.
8. Mofenson L.M., Lambert J.S., Stiehm E.R., et al. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. N Engl J Med 1999, 341:385-393.
9. Cooper E.R., Charurat M., Mofenson L., et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1 infected women and prevention of perinatal HIV-1 transmission. Women and Infants' Transmission Study Group. J Acquir Immune Defic Syndr 2002, 29:484-494.
10. Centers for Disease Control and Prevention Recommendations of the US Public Health Services Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 1994, 43:1-20.
11. Centers for Disease Control and Prevention U.S. Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. MMWR Recomm Rep 1995, 44:1-15.
12. Sperling R.S., Shapiro D.E., Coombs R.W., et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. N Engl J Med 1996, 335:1621-1629.
13. Chuachoowong R., Shaffer N., Siriwasin W., et al. Short course antenatal zidovudine reduces both cervicovaginal HIV-1 RNA levels and risk of perinatal transmission. J Infect Dis 2000, 181:99-106.
14. Su-Win S., Caliendo A.M., Reinert S. Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA. AIDS 2000, 14:415-421.
15. Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States p. 1-17. Available at:, Accessed June 13, 2010. http://aidsinfo.nih.gov/ContentFiles/PerinatalGL.pdf.
16. Jackson J.B., Musoke P., Fleming T., et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Lancet 2003, 362(9387):859-868.
17. Petra Study Team Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial. Lancet 2002, 359(9313):1178-1186.
18. Miotti P.G., Taha T.E., Kumwenda N.I., et al. HIV transmission through breastfeeding: a study in Malawi. JAMA 1999, 282:744-749.
19. Gaur A., Dominguez K.L., Kalish M.L., et al. Practice of feeding premasticated food to infants: a potential risk factor for HIV transmission. Pediatrics 2009, 124:658-666.
20. Lindegren M.L., Byers R.H., Thomas P., et al. Trends in perinatal transmission of HIV/AIDS in the United States. JAMA 1999, 282:531-538.
21. Centers for Disease Control and Prevention HIV/AIDS surveillance report Available at:, Accessed June 13, 2010. http://www.cdc.gov/hiv/surveillance/resources/reports/2008report/table5a.htm.
22. Peters V., Liu K., Dominguez K., et al. Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, pediatric spectrum of HIV disease cohort. Pediatrics 2003, 111(5):1186-1191.
23. Branson B.M., Handsfield H.H., Lampe M.A., et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 2006, 55:1-17.
24. Wallihan R., Koranyi K., Brady M. Perinatally human immunodeficiency virus-1 infected children born to low risk mothers who tested antibody negative during pregnancy. Pediatr Infect Dis J 2010, 29(3):274-275.
25. Committee on Pediatric AIDS HIV testing and prophylaxis to prevent mother-to-child transmission in the United States. Pediatrics 2008, 122:1127-1134.
26. Read J.S. Diagnosis of HIV-1 infection in children younger than 18 months in the United States. Pediatrics 2007, 120:e1547-e1562.
27. Kovacs A., Xu J., Rasheed S., et al. Comparison of a rapid nonisotopic polymerase chain reaction assay with four commonly used methods for the early diagnosis of human immunodeficiency virus type 1 infection in neonates and children. Pediatr Infect Dis J 1995, 14(11):948-954.
28. Centers for Disease Control and Prevention (CDC) Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years-United States, 2008. MMWR Recomm Rep 2008, 57(RR-10):1-12.
29. Adjorlolo-Johnson G., De Cock K.M., Ekpini E., et al. Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast. JAMA 1994, 272(6):462-466.
30. Padua E., Almeida C., Nunes B., et al. Assessment of mother-to-child HIV-1 and HIV-2 transmission: an AIDS reference laboratory collaborative study. HIV Med 2009, 10(3):182-190.
31. Galli L., de Martino M., Tovo P., et al. Onset of clinical signs in children with HIV-1 perinatal infection. AIDS 1995, 9:455-461.
32. Wade N.A., Birkhead G.S., Warren B.L., et al. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J Med 1998, 339(20):1409-1414.
33. Simonds R.J., Oxtoby M.J., Caldwell M.B., et al. Pneumocystis carinii pneumonia among US children with perinatally acquired HIV infection. JAMA 1993, 270:470-473.
34. Centers for Disease Control and Prevention Guidelines for the Prevention and Treatment of Opportunistic Infections Among HIV-Exposed and HIV-Infected Children. MMWR Recomm Rep 2009, 58(No. RR11):45-50.
35. Centers for Disease Control and Prevention Recommended Immunization schedule for persons aged 0 through 6 years-United States Available at:, Accessed June 13, 2010. http://www.cdc.gov/vaccines/rec/acip.